Search

Your search keyword '"Ansotegui, Ignacio J"' showing total 521 results

Search Constraints

Start Over You searched for: Author "Ansotegui, Ignacio J" Remove constraint Author: "Ansotegui, Ignacio J"
521 results on '"Ansotegui, Ignacio J"'

Search Results

1. Global change, climate change, and asthma in children: Direct and indirect effects - A WAO Pediatric Asthma Committee Report

2. Concepts for the Development of Person-Centered, Digitally Enabled, Artificial Intelligence–Assisted ARIA Care Pathways (ARIA 2024)

3. Time to ACT-UP: Update on precautionary allergen labelling (PAL)

4. World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) guideline update – XI – Milk supplement/replacement formulas for infants and toddlers with CMA – Systematic review

6. The international WAO/EAACI guideline for the management of hereditary angioedema – The 2021 revision and update

7. Updated grading system for systemic allergic reactions: Joint Statement of the World Allergy Organization Anaphylaxis Committee and Allergen Immunotherapy Committee

8. Global disparities in availability of epinephrine auto-injectors

9. Refractory Anaphylaxis: A New Entity for Severe Anaphylaxis

10. Cutoff Values of MASK-air Patient-Reported Outcome Measures

11. WAO consensus on DEfinition of Food Allergy SEverity (DEFASE)

12. The Allergic Rhinitis and Its Impact on Asthma (ARIA) Approach of Value-Added Medicines: As-Needed Treatment in Allergic Rhinitis

14. World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) guideline update – XIII – Oral immunotherapy for CMA – Systematic review

15. WAO-ARIA consensus on chronic cough – Part III: Management strategies in primary and cough-specialty care. Updates inCOVID-19

16. Aktualisiertes Klassifikationssystem für systemische allergische Reaktionen: Gemeinsame Stellungnahme des World Allergy Organization Anaphylaxis Committee und des Allergen Immunotherapy Committee.

19. WAO-ARIA consensus on chronic cough - Part II: Phenotypes and mechanisms of abnormal cough presentation — Updates inCOVID-19

20. WAO-ARIA consensus on chronic cough – Part 1: Role of TRP channels in neurogenic inflammation of cough neuronal pathways

22. Update on latex allergy: New insights into an old problem

25. Current situation of allergy education in Mexico and other parts of Latin America

26. Consensus on DEfinition of Food Allergy SEverity (DEFASE) an integrated mixed methods systematic review

27. COVID-19 vaccine-associated anaphylaxis: A statement of the World Allergy Organization Anaphylaxis Committee

28. Allergy and coronavirus disease (COVID-19) international survey: Real-life data from the allergy community during the pandemic

29. Air pollution and indoor settings

30. Does Comorbid Food Allergy Affect Response to Omalizumab in Patients with Asthma?

31. Concurrent validity, cut‐offs and ability to change of patient‐reported outcome measures for rhinitis and asthma in MASK‐air®.

32. Why fexofenadine is considered as a truly non-sedating antihistamine with no brain penetration: a systematic review.

33. Consensus on DEfinition of Food Allergy SEverity (DEFASE): Protocol for a systematic review

35. World Allergy Organization Anaphylaxis Guidance 2020

36. Medical devices in allergy practice

38. Beliefs and preferences regarding biological treatments for severe asthma

39. COVID-19, asthma, and biological therapies: What we need to know

40. Acute asthma management during SARS-CoV2-pandemic 2020

41. International expert consensus on the management of allergic rhinitis (AR) aggravated by air pollutants: Impact of air pollution on patients with AR: Current knowledge and future strategies

42. IgE allergy diagnostics and other relevant tests in allergy, a World Allergy Organization position paper

43. A WAO — ARIA — GA2LEN consensus document on molecular-based allergy diagnosis (PAMD@): Update 2020

44. Poor rhinitis and asthma control is associated with decreased health-related quality-of-life and utilities: A MASK-air study

45. MASK-air®: An OECD (Organisation for Economic Coordination and Development) Best Practice for Public Health on integrated care for chronic diseases.

46. Mobile Technology in Allergic Rhinitis: Evolution in Management or Revolution in Health and Care?

47. Mobile technology offers novel insights into the control and treatment of allergic rhinitis: The MASK study

48. Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology

49. Doxofylline as a steroid-sparing treatment in Mexican children with asthma.

50. Green roof gardens – Selecting allergy friendly vegetation: a GA2LEN position paper

Catalog

Books, media, physical & digital resources